AB 2279: Childhood lead poisoning prevention.
- Session Year: 2019-2020
- House: Assembly
- Latest Version Date: 2020-05-12
|
Date
|
Status
|
|---|---|
| Jun 23, 2020 | Referred to Com. on HEALTH. |
| Jun 9, 2020 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Jun 8, 2020 | Read third time. Passed. Ordered to the Senate. (Ayes 76. Noes 0. Page 4726.) |
| Jun 3, 2020 | Read second time. Ordered to Consent Calendar. |
| Jun 2, 2020 | From committee: Do pass. To Consent Calendar. (Ayes 18. Noes 0.) (June 2). |
| May 19, 2020 | From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (May 18). Re-referred to Com. on APPR. |
| May 13, 2020 | Re-referred to Com. on HEALTH. |
| May 12, 2020 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Feb 24, 2020 | Referred to Coms. on HEALTH and E.S. & T.M. |
| Feb 15, 2020 | From printer. May be heard in committee March 16. |
| Feb 14, 2020 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Jun 8, 2020 | AB 2279 Cristina Garcia Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Jun 2, 2020 | Do pass. To Consent Calendar. | Assembly Standing Committee on Appropriations |
Passed |
|
| May 18, 2020 | Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar | Assembly Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Date of Hearing: June 2, 2020
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Lorena Gonzalez, Chair
ABPCA Bill Id:AB 2279
Author:(Cristina Garcia) – As Amended Ver:May 12, 2020
Policy Committee: | Health | Vote: | 15 - 0 |
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill implements two recommendations of a recent state audit related to blood lead screening tests for children. Specifically, this bill:
- Requires the California Department of Public Health (CDPH), in development of the standard of care whereby all children are evaluated for risk of lead poisoning during a periodic health assessment, to consider several additional personal and environmental risk factors to determine whether a child is at risk and recommended for routine blood lead screening tests.
- Requires CDPH to update its formula for allocating lead poisoning prevention funds to local agencies.
FISCAL EFFECT:
Costs to CDPH to add additional risk factors into a planned rulemaking are minor and absorbable (Childhood Lead Poisoning Prevention Fund).
COMMENTS:
- Purpose. According to the author, this bill is needed to ensure CDPH appropriately updates the funding formula it uses to allocate money to local lead poisoning prevention programs and adds additional known risk factors to identify children at for lead poisoning and thereby recommended for a routine blood lead screening test.
The author states AB 1316 (Quirk and C. Garcia), Chapter 507, Statutes of 2017, required CDPH to address these two issues. The author contends the State Auditor’s recently released report shows that CDPH has not demonstrated effective management of their Childhood Lead Poisoning Prevention Program (CLPPP) or met the statutory requirements of AB 1316.
- Background. Lead is harmful to neural development of children and no level of lead in the blood is safe. According to the CDC, at least four million households include children who are being exposed to high levels of lead. Children are exposed to lead from different sources (such as paint, gasoline, solder, and consumer products like candy, artificial turf, and toys) and through different pathways (such as air, food, water, dust and soil). Although there are several exposure sources, lead-based paint is the most widespread and dangerous high-dose source of lead exposure for young children. Because there is no safe level of lead and no treatment for lead poisoning, two main public health strategies are employed: educating parents and caregivers about identifying and keeping children safe from lead hazards, and preventing lead poisoning through environmental remediation.
If a blood test shows a high blood lead level, a child is contacted by a state-contracted, locally administered case management program that includes public health nursing and environmental follow-up to detect and eliminate lead exposure pathways. The case management function is overseen by the CLPPP within CDPH. Case management includes finding and eliminating the source of the lead, instruction in personal and household hygiene measures, optimizing the child's diet and nutritional status, and close follow-up.
- Who is Screened for Blood Lead Levels? All children enrolled in publicly funded health care programs (e.g., Medi-Cal) are considered part of the target population for blood lead screening, which also includes children living in older homes. Blood lead screening is also recommended for children at certain ages who are deemed “at risk” pursuant to existing guidance and regulation. Current law and regulation requires providers to administer such tests.
- Definition of “At-Risk.” AB 1316 (Quirk and C. Garcia), Chapter 507, Statutes of 2017 requires CDPH to revise its regulations for the CLPPP to redefine the assessment of risks for the purposes of evaluating a child's risk for lead exposure. Specifically, AB 1316 required the regulations to include the determination of risk factors for whether a child is “at risk” and recommended for testing. When determining the risk factors, DPH is required to consider the most significant environmental risk factors, including, but not limited to, a child’s time spent in a home, school or building built before 1978, a child’s proximity to a former lead or steel smelter or an industrial facility that historically emitted or currently emits lead, a child’s proximity to a freeway or heavily traveled roadway, other potential risk factors for lead exposure, and known sources of lead contamination. By July 1, 2019, the regulations were required to be developed in consultation with medical experts, environmental experts, appropriate professional organizations, the public and others as determined by the department. Regulations have not yet been updated pursuant to AB 1316.
- California State Audit on Childhood Lead Levels. In January 2020, the California State Auditor released an audit entitled “Childhood Lead Levels – Millions of Children in Medi-Cal Have Not Received Required Testing for Lead Poisoning.” The audit is critical of DHCS and CDPH, finding millions of children who should have been tested for elevated lead levels have not received all of the recommended tests because DHCS and CDPH have failed to adequately accomplish their respective duties. The State Auditor made a large number of recommendations to improve accountability, two of which this bill addresses. Specifically, the recommendations and CDPH’s responses are below.
- The Auditor recommended CDPH update the definition of “at risk” children to include more potential sources of exposure.
In response, CDPH indicated it is promulgating regulations expanding the risk factor criteria pursuant to AB 1316. CDPH notes promulgating regulations is generally a three-year process for non-emergency regulations. To date, CDPH has held public stakeholder meetings and the department indicates it is on track to formally notice the rule making in fall 2020.
With respect to identifying additional sources of lead exposure to define “at risk” children for purposes of lead screening, CDPH developed a revised “Standard of Care Guidelines” document that incorporates the new statutory requirements. The guidance document lists a wide range of potential sources of exposure to lead as outlined in the statute, and indicates providers should test for blood lead levels if a provider believes there is reason a child may have been exposed through one or more of the exposure sources listed. This guidance document is not an official regulation, but providers commonly rely on guidance issued by CDPH to guide practice related to issues of public health concern.
- The Auditor recommended that CDPH develop a new funding allocation methodology that accounts for the number of lead-poisoned children in each jurisdiction. The audit found CDPH used a formula based on outdated data that has led to dramatically different amounts of funding per child with lead poisoning in different jurisdictions. Additionally CDPH did not maintain documentation specifying how or when it calculated the funding allocations.
In response, CDPH agreed it would update the local prevention programs’ funding allocations using recent data in the next contract cycle, by June 2020.
Also in its response to the audit, CDPH states it has drafted the 2019 biennial report, “Update on California's Progress in Preventing and Managing Childhood Lead Exposure,” and plans to release it later this year.
- Related Legislation. AB 2060 (Holden), pending in this committee, amends the California Safe Drinking Water Act (CSDWA) to define “lead free,” for purposes of manufacturing, industrial processing, or conveying or dispensing water for human consumption, to mean not more than one microgram of lead under certain tests and meeting a specified certification when used with respect to end-use devices.
AB 2276 (Reyes), pending in this committee, requires notification when a child misses a required blood lead screening test and reminders to health care providers of the need to perform required blood lead screening tests, as well as goals, reporting and a number of other requirements that address blood lead screening.
AB 2277 (Salas, Cristina Garcia, Quirk and Reyes), pending in this committee, contains provisions similar to those in this bill that establish notification when a child misses a required blood lead screening test and reminders to health care providers of the need to perform required blood lead screening tests.
AB 2278 (Quirk) addresses data matching for blood lead screening laboratory results. AB 2278 is in the Assembly Health Committee but is no longer being pursued by the author.
AB 2422 (Grayson) addresses data matching for blood lead screening laboratory results and requires a public registry of lead-contaminated locations reported to CDPH pursuant to current law. AB 2422 is in the Assembly Health Committee but is no longer being pursued by the author.
AB 2488 (Gonzalez), currently in the Assembly Rules Committee, is a spot bill amending the Lead-Safe Schools Protection Act (the Act requires CDPH to perform various activities related to reducing the risk of exposure to lead hazards in public schools).
AB 2677 (Santiago), pending in the Environmental Safety and Toxics Materials Committee, creates in the California Environmental Protection Agency the position of community liaison, the duties of which would include community outreach and dissemination of information relating to cleanup of the lead contamination in the areas surrounding the Exide Technologies facility in the City of Vernon and coordination with the Department of Toxic Substances Control to address issues raised by residents affected by the lead contamination in the areas surrounding the Exide Technologies facility.
SB 1008 (Leyva), pending in Senate Health Committee, requires CDPH to design, implement, and maintain an online lead information registry and use registry information while protecting privacy and confidentiality of nonpublic information.
- Prior Legislation. AB 2122 (Reyes), of the 2017-18 Legislative Session, was similar to AB 2276, which is pending in committee. AB 2122 was vetoed. The veto message noted Governor Brown’s desire to allow DHCS to continue working with MCMC plans, health care providers and public health officials to determine what additional policies and practices may be necessary to improve screening rates.
Analysis Prepared by: Lisa Murawski / APPR. / (916) 319-2081
Date of Hearing: May 18, 2020
ASSEMBLY COMMITTEE ON HEALTH
Jim Wood, Chair
ABPCA Bill Id:AB 2279
Author:(Cristina Garcia) – As Amended Ver:May 12, 2020
SUBJECT: Childhood lead poisoning prevention.
SUMMARY: Adds several additional risk factors required to be considered as part of the standard of care for a lead poisoning evaluation of children required to be established by the California Department of Public Health (DPH) in regulation, such as a child’s residency in or visit to a foreign country, their residency in a high-risk ZIP Code, a child’s proximity to current or former lead-producing facilities. Requires DPH to develop, by January 1, 2021, the regulations on the additional risk factors, in consultation with the specified individuals in existing law. Requires DPH to update its formula for allocating funds to any local agency that contracts with DPH to administer the Childhood Lead Poisoning Prevention Program (CLPPP), and to revise funding allocations before each contract cycle. Specifically, this bill:
- Adds the following risk factors required to be considered as part of the standard of care required to be established by DPH in regulation that all children are evaluated for risk of lead poisoning by health care providers during each child’s periodic health assessment:
- A child’s residency in or visit to a foreign country;
- A child’s residency in a high-risk ZIP Code;
- A child who has a sibling or playmate with lead poisoning;
- The likelihood of a child placing nonfood items in the mouth;
- A child’s proximity to current or former lead-producing facilities; and,
- The likelihood of a child using food, medicine, or dishes from other countries.
- Requires DPH to develop, by January 1, 2021, the regulations on the additional risk factors, in consultation with medical experts, environmental experts, appropriate professional organizations, the public, and others as determined by DPH, as specified in existing law.
- Requires DPH, to ensure that CLPPP funds are allocated to each local agency equitably and commensurate with the level of services needed to provide to children diagnosed with lead poisoning, to:
- Update its formula for allocating funds to any local agency that contracts with DPH to administer the CLPPP; and,
- Revise funding allocations before each contract cycle.
- Requires DPH, when revising the allocation formula, to take into account the most recent data for the number of children with elevated blood levels in each jurisdiction.
- Defines “elevated blood lead levels" to mean a blood lead level no higher than the blood lead reference value as specified in the most recent United States Centers for Disease Control and Prevention guidelines.
EXISTING LAW:
- Establishes as the goal of the state that all children at risk of lead exposure receive blood lead screening tests.
- Requires DPH to adopt regulations establishing a standard of care, at least as stringent as the most recent federal Centers for Disease Control and Prevention (CDC) screening guidelines, whereby all children are evaluated for risk of lead poisoning by health care providers during each child’s periodic health assessment.
- Requires the regulations to meet the goal that all children at risk of lead exposure receive blood lead screening tests, and to include the determination of risk factors for whether a child is “at risk.”
- Requires DPH, when determining the risk factors, to consider the most significant environmental risk factors, including, but not limited to:
- A child’s time spent in a home, school, or building built before 1978;
- A child’s proximity to a former lead or steel smelter or an industrial facility that historically emitted or currently emits lead;
- A child’s proximity to a freeway or heavily traveled roadway, other potential risk factors for lead exposure; and,
- Known sources of lead contamination.
- Requires the regulations, by July 1, 2019, to be developed in consultation with medical experts, environmental experts, appropriate professional organizations, the public, and others as determined by DPH.
- Requires the standard of care to:
- Require a child who is determined to be “at risk” for lead poisoning to be screened, according to the regulations adopted;
- Provide that a child not be screened if the parent or guardian of the child refuses to consent to the screening; and,
- Provide that health care providers are responsible only for evaluation of all children, for screening of children determined to be at risk, and for medically necessary follow-up services.
- Requires, pursuant to state regulation, every health care provider who performs a periodic health assessment of a child at the ages below to comply with the following standard of care:
- Provide oral or written anticipatory guidance to a parent or guardian of the child, including, at a minimum, the information that children can be harmed by exposure to lead, especially deteriorating or disturbed lead-based paint and the dust from it, and are particularly at risk of lead poisoning from the time the child begins to crawl until 72 months of age;
- If the child receives services from a publicly funded program for low-income children, order the child screened for lead poisoning as the child is presumed to be at risk of lead poisoning; and,
- If the child does not receive services from a publicly funded program for low-income children, evaluate the child's risk of lead poisoning by asking a parent or guardian of the child the following question: “Does your child live in, or spend a lot of time in, a place built before 1978 that has peeling or chipped paint or that has been recently renovated?” If the parent or guardian answers “yes” or “don't know” to the question, order the child screened for lead poisoning.
- Requires, pursuant to state regulation, the health care provider to perform the actions above at each of the following times:
- Requires the anticipatory guidance required 7a) to be performed at each periodic health assessment, starting at six months of age and continuing until 72 months of age; and,
- Requires the screening and evaluation required by 7c) to be performed:
- When the child is 12 months of age;
- When the child is 24 months of age;
- Whenever the health care provider performing a periodic health assessment becomes aware that the child is 12 months to 24 months of age and the actions specified in 7b) and c) above were not taken at 12 months of age or thereafter;
- Whenever the health care provider performing a periodic health assessment becomes aware that the child is 24 months to 72 months of age and the actions specified in 7b) and c) above were not taken when the child was 24 months of age or thereafter; and,
- Whenever the health care provider performing a periodic health assessment of a child 12 to 72 months of age becomes aware that, in the professional judgment of the health care provider, a change in circumstances has put the child at risk of lead poisoning.
FISCAL EFFECT: This bill has not been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, lead has been listed under California's Proposition 65 since 1987 as a substance that can cause reproductive damage and birth defects, and has been listed as a chemical known to cause cancer since 1992. There is no level of lead that has been proven safe, either for children or for adults. Under the CLPPP, the DPH’s regulations require physicians to give all children "anticipatory guidance" on lead, whereby the physicians tell children and their parents why lead is a hazard, and then evaluate children for lead exposure. Additionally, those regulations require physicians to order a blood lead screening for all children on a publicly funded program for low-income children or children who are deemed at high risk for lead exposure. Currently, when physicians are evaluating children for possible lead exposure they only ask one question; “Does your child live in, or spend a lot of time in, a place built before 1978 that has peeling or chipped paint or that has been recently renovated?" It has become common knowledge that old houses are not the only potential place children could potentially become exposed to lead. For example, living near an old lead smelter, industrial facilities with lead air emissions, contact with leaded jewelry, and drinking water from lead-contaminated plumbing can all lead to high lead exposure risk, among many other exposure pathways in daily life. The author argues that, for too long communities of color, brown and black communities have been treated like wastelands, and children in communities like mine have fallen through the cracks of the health care system they trust to keep them safe. The author states that, in 2017, Assemblymember Quirk and she authored AB 1316 that among other things required DPH to update their funding formula and add additional known risk factors for lead poisoning. The State Auditor’s recently released report shows that DPH has not demonstrated effective management of their CLPPP or met the statutory requirements of AB 1316. This bill will bring accountability to the health care systems that we rely on to keep us healthy, and will ensure that our children receive the proper care under the CLPPP by requiring DPH to update its Local Prevention Program Funding Allocation Methodology to guarantee a more equitable distribution of funds based on the levels of lead poisoning found in local communities. Finally, this bill will require DPH to add several known risk factors for elevated blood lead levels that medical providers must consider when determining if children are at risk for lead poisoning.
- BACKGROUND. According to the CDC, at least four million households include children who are being exposed to high levels of lead. Children are exposed to lead from different sources (such as paint, gasoline, solder, and consumer products like candy, artificial turf, and toys) and through different pathways (such as air, food, water, dust, and soil). Although there are several exposure sources, lead-based paint is the most widespread and dangerous high-dose source of lead exposure for young children. There are approximately half a million U.S. children ages one to five years with BLLs above five micrograms per deciliter (µg/dL), a level at which CDC recommends public health actions be initiated. No safe BLL in children has been identified, and exposure can affect nearly every system in the body. Because lead exposure often occurs with no obvious symptoms, it frequently goes unrecognized. Children at higher risk for lead exposure are poor, are members of racial-ethnic minority groups, are recent immigrants, live in older, poorly maintained rental properties, or have parents who are exposed to lead at work.
In California, the CLPPP, within DPH, provides services to the community for the purpose of increasing awareness regarding the hazards of lead exposure, reducing lead exposure, and increasing the number of children assessed and appropriately blood tested for lead poisoning. The CLPPP program offers home visitation, environmental home inspections, and nutritional assessments to families of children found to be severely lead poisoned. The CLPPP provides telephone contacts and educational materials to families of lead-poisoned and lead-exposed children. The CLPPP provides information and education to the general public, medical providers, and community-based organizations. - CALIFORNIA STATE AUDITOR AUDIT ON CHILDHOOD LEAD LEVELS. In January 2020, the California State Auditor (CSA) released an audit entitled “Childhood Lead Levels – Millions of Children in Medi-Cal Have Not Received Required Testing for Lead Poisoning.” The CSA audit is critical of the Department of Health Care Services (DHCS) and DPH, stating that millions of children who should have been tested for elevated lead levels have not received all of the tests they should have because DHCS and DPH have failed to adequately accomplish the duties with which they have been entrusted. The Auditor found children enrolled in Medi-Cal often have not received the medical tests needed to identify elevated lead levels even though the State mandates such testing. With limited exceptions, California requires that children enrolled in Medi-Cal receive tests for elevated lead levels at the ages of one and two years. However, according to DHCS’ data, millions of children in Medi-Cal did not receive the lead tests they should have. These data show that from fiscal years 2009–10 through 2017–18, more than 1.4 million of the 2.9 million one- and two-year old children enrolled in Medi-Cal did not receive any of the required tests and another 740,000 children missed one of the two tests. According to DHCS’ data, the rate of eligible children receiving all of the tests that they should have was less than 27%. CSA states that many of these children live in areas of the State with high occurrences of elevated lead levels, making the low testing rates even more troubling.
- FUNDING ALLOCATIONS FOR LOCAL PREVENTION PROGRAMS. Related to the funding allocation provision in this bill, the Auditor stated DPH has allocated funding to local prevention programs based on a funding formula that uses outdated information on the number of children with lead poisoning in each jurisdiction. The CSA states that, according to CDPH’s administrative section chief, it generally bases funding for the local prevention programs on a number of factors, including an area’s number of low-income children, its number of children in older housing, and the number of children with lead poisoning in the county in which the program is located. However, CDPH did not maintain documentation specifying how or when it calculated the proportions in which it distributes funds, so it had to recreate that analysis in response to CSA’s request for information. The CSA stated that, during the contract period for fiscal years 2017–18 through 2019–20, the allocations to local prevention programs did not align with the numbers of children with lead poisoning for which the programs are responsible. CSA states this funding formula has led to significant differences in the services that local prevention programs have been able to provide to children with lead poisoning. For example, DPH allocated the Riverside County local prevention program almost $550,000 in basic funding, while it allocated the Sacramento County local prevention program—which had twice as many children with lead poisoning—only $409,000.
DPH indicates the allocation to locals for FY 2019-20 is $17.8 million. DPH indicates the allocation formula was last updated in Fall 2019 for the three-year contract cycle beginning July 1, 2020. DPH indicates the formula currently used to allocate funds includes the criteria below. Each of these criteria are weighted.
- Estimated number of children in each jurisdiction considered at high risk and mandated to be screened under current regulations.
- Estimated number of Medi-Cal eligible children under age 6; and,
- Estimated number of children under age 6 living in pre-1960 and pre-1960 to pre-1979 housing.
- Number of children in each jurisdiction with blood lead levels (BLLs) above the CDC reference value for lead of 5 micrograms per deciliter (mcg/dL); (DPH rounds BLL values, so this includes children with BLLs ≥ 4.5 mcg/dL). DPH provides tiered services to these children based on BLL.
- Number of new cases with BLLs ≥ 9.5 mcg/dL meeting the current criteria for full case management services;
- Number of children with blood lead levels BLLs ≥ 9.5 mcg/dL but not meeting the current full case management criteria; and,
- Number of children with BLLs 4.5 to 9.4 mcg/dL.
To help ensure local programs are able to provide the services needed, there is a minimum allocation given to the smaller jurisdictions, even if the allocation calculated by the formula is lower.
- STANDARD OF CARE REGULATIONS. This bill would add several additional risk factors required to be considered as part of the standard of care for a lead poisoning evaluation of children required to be established by the DPH in regulation, such as a child’s residency in or visit to a foreign country, their residency in a high-risk ZIP Code, a child’s proximity to current or former lead-producing facilities.
AB 1316 (Quirk), Chapter 507, Statutes of 2017 requires DPH to revise its regulations for the CLPPP to redefine the assessment of risks for the purposes of evaluating a child's risk for lead exposure. Specifically, AB 1316 required the regulations to include the determination of risk factors for whether a child is “at risk.” When determining the risk factors, DPH is required to consider the most significant environmental risk factors, including, but not limited to, a child’s time spent in a home, school, or building built before 1978, a child’s proximity to a former lead or steel smelter or an industrial facility that historically emitted or currently emits lead, a child’s proximity to a freeway or heavily traveled roadway, other potential risk factors for lead exposure, and known sources of lead contamination. By July 1, 2019, the regulations were required to be developed in consultation with medical experts, environmental experts, appropriate professional organizations, the public, and other as determined by the department. Finally, the standard of care is required require a child who determined to be “at risk” for lead poisoning according to the regulation adopted to be screened. Regulations have not been updated pursuant to AB 1316. CSA recommended DPH, to better ensure that children with lead poisoning are identified and treated, should prioritize meeting legislative requirements related to these issues, including (by March 2020), finish developing the lead risk evaluation regulations and include in them multiple risk factors, such as those used in lead risk evaluation questionnaires in other states, and commence the formal rulemaking process. - Percentage of Medi-Cal children up to age three receiving BLL screening. In 2018, DHCS and DPH provided the Assembly Environmental Safety and Toxics Material Committee (ESTM Committee) with an updated percentage of the number of children in Medi-Cal who have received a BLL screening test for an oversight hearing by that committee conducted in February 2018. BLL data collected by DHCS and DPH is very different. Medi-Cal data is based on the submittal of a claim or encounter that includes specific procedure and diagnosis codes that indicate a BLL screening has been performed. DHCS receives administrative data in the forms of claims (for fee-for-service beneficiaries) or encounter data (for Medi-Cal managed care enrollees). Such data only indicates a BLL test occurred if Medi-Cal was billed specifically for a BLL test. DHCS’ data would not indicate the completion of a BLL test if a primary care provider performed the test but only billed for an office visit. In contrast, DPH receives data on BLL tests performed at laboratories, including those in a physician’s office. DPH has limited data on who is and who is not a Medi-Cal beneficiary. When the data from DPH is added to the data from DHCS, the percentage of children 12 to 23 months old who were continuously enrolled in Medi-Cal for a year for a year and who were screened for lead was 48.8%. Among those 24 to 35 months old, the percentage of children screened was 40.5%.
- SUPPORT. The Coalition of California Welfare Rights Organizations, Inc. (CCWRO) writes in support that this bill has three goals: First, it adds specific risk factors to the regulatory standard of care that apply when a child is at risk of lead poisoning, including a list of items currently codified in New York State Law. These factors include a child’s recent immigration status, residency, or visits to a foreign country. Second, it requires DPH to develop regulations consistent with the new proposed statutory requirements by January 1, 2021. CCWRO writes that the need to expand California’s blood lead screening standards of care was identified and discussed in the CSA audit that indicated California’s Medi-Cal blood lead screening compliance level was at an unacceptable rate of 36.1% of eligible children tested. Third, it would require DPH to update its funding formulas for local public health agencies to fund lead poisoning services.
- RELATED LEGISLATION.
- AB 2060 (Holden) would amend the California Safe Drinking Water Act (CSDWA) to define “lead free,” for purposes of manufacturing, industrial processing, or conveying or dispensing water for human consumption, to mean not more than one microgram of lead under certain tests and meeting a specified certification when used with respect to end-use devices. The CSDWA requires the State Water Resources Control Board to administer provisions relating to the regulation of drinking water to protect public health, and the CSDWA prohibits, with certain exceptions, the use of any pipe, pipe or plumbing fitting or fixture, solder, or flux that is not lead free in the installation or repair of any public water system or any plumbing in a facility providing water for human consumption. The CSDWA currently defines “lead free” for purposes of manufacturing, industrial processing, or conveying or dispensing water for human consumption to mean not more than 0.2% lead when used with respect to solder and flux and not more than a weighted average of 0.25% lead when used with respect to the wetted surfaces of pipes and pipe fittings, plumbing fittings, and fixtures. AB 2060 is awaiting hearing in the Assembly Appropriations Committee.
- AB 2276 (Reyes, Cristina Garcia, Quirk, and Reyes) establishes statutory state goals for blood lead screening tests for children, and requires the Department of Health Care Services (DHCS) to annually post on its internet website a report detailing its progress toward the goals. Requires a contract between DHCS and a Medi-Cal managed care (MCMC) plan to ensure that the MCMC plan and its contracting health care providers who are responsible for the period health assessment of a child pursuant to state regulation meet the standard of care for lead-related anticipatory guidance, screening and evaluation required pursuant to state law and regulation. Requires the MCMC plan to notify the child’s health care provider when the child misses a required blood lead screening test within 30 days of the missed test. AB 2276 is scheduled for hearing in the Assembly Health Committee on May 18, 2020.
- AB 2277 (Salas, Cristina Garcia, Quirk, and Reyes) requires DHCS to notify the parent or guardians charged with the support of a child who enrolled in Medi-Cal when that child misses a required blood lead screening test. Requires a contract between DHCS and a Medi-Cal managed care (MCMC) plan to impose on the plan, the requirement to identify every enrollee who is a child without any record of completing required blood lead screening tests on a monthly basis, and to remind the responsible health care provider of the need to perform required blood lead screening tests. AB 2277 is scheduled for hearing in the Assembly Health Committee on May 18, 2020.
- AB 2278 (Quirk, Cristina Garcia, Grayson, Reyes, and Salas) requires an analyzing laboratory that performs a blood lead analysis to also report to DPH the person’s telephone number in addition to the person’s address and ZIP code if the analyzing laboratory has that information, and the Medi-Cal identification number and medical plan identification number, if available. Requires the existing “within 30 calendar day” timeframe for an analyzing laboratory to report less to DHP a blood lead test of less than 10 micrograms per deciliter begins from the date of the analysis. AB 2278 is in the Assembly Health Committee but is no longer being pursued by the author.
- AB 2422 (Grayson) would add to the information that a laboratory is required to report to DPH when it performs a blood lead analysis test to include the Medi-Cal identification number, or other equivalent medical identification number of the person tested. Requires, if the person tested is a minor, that the laboratory include the person’s contact information and a unique identifier, in a form to be determined by DHCS, as specified. Requires DPH to develop and maintain on its internet website a public registry of lead-contaminated locations reported to DPH pursuant to the provisions relating to lead hazards in buildings. Requires DPH to ensure that personally identifiable information, including medical information, is not disclosed or ascertainable from the information available on the registry. AB 2422 is in the Assembly Health Committee but is no longer being pursued by the author.
- AB 2488 (Gonzalez) is a spot bill amending the Lead-Safe Schools Protection Act (the Act requires the DPH to perform various activities related to reducing the risk of exposure to lead hazards in public schools, as defined, including, among other activities, conducting a sample survey to determine the likely extent and distribution of lead exposure to children from paint on the school, soil in play areas at the school, drinking water at the tap, and other potential sources identified by DPH for this purpose, as provided). AB 2488 is in the Assembly Rules Committee.
- AB 2677 (Santiago) would create in the California Environmental Protection Agency, under the direction of the Secretary for Environmental Protection, the position of community liaison, the duties of which would include, but are not limited to, community outreach and dissemination of information relating to cleanup of the lead contamination in the areas surrounding the Exide Technologies facility in the City of Vernon and coordination with the Department of Toxic Substances Control to address issues raised by residents affected by the lead contamination in the areas surrounding the Exide Technologies facility. AB 2677 is awaiting hearing in the Environmental Safety and Toxics Materials Committee.
- SB 1008 (Leyva) would require DPH to: i) design, implement, and maintain an online lead information registry on its internet website that enables the public to determine the lead inspection and abatement status for properties; and, ii) use information it maintains for the registry to the extent that DHP ensures that any personally identifying information, including medical information, is made unavailable to the public. SB 1008 is awaiting hearing in the Senate Health Committee.
- PREVIOUS LEGISLATION.
- AB 2122 (Reyes) of 2018 would have: a) established requirements DHCS and MCMC care plans to ensure children receive blood lead screening, information about lead exposure and testing, and follow-up services for children with an elevated blood lead level, including a contractual requirement for plans and their contractors to meet the standard of care for lead testing; b) establishes state goals for children at risk of lead exposure and for blood testing for children under age who are eligible for Medi-Cal; c) requires DHCS to include blood lead screening tests as a plan performance measure in its annual External Accountability Set, and requires DHCS to annually create a report detailing the DHCS’ progress toward the state goals; and, d) require DPH to prepare provider training guidelines, curriculum, and resources that are required to be used to educate providers about childhood lead poisoning prevention, childhood lead exposure risks, childhood lead exposure health effects, and sources of childhood lead exposure at the state, regional, and local levels.
AB 2122 was vetoed by Governor Brown, who stated that “lead exposure in children is a serious health concern and I share the author's desire to increase the number of Medi-Cal children who are screened. The department, however, already requires in its contracts with managed care plans and providers that children receive screenings in accordance with federal and state regulations. Updated and more thorough data on periodic screening tests is being developed with DPH to assist in tracking compliance. I believe the department should continue its current efforts working with managed care plans, health care providers and public health officials to determine what additional policies and practices may be necessary to improve screening rates. - SB 1097 (Hueso), Chapter 691, Statutes of 2018 requires DHP’s report regarding the effectiveness of appropriate lead poisoning case management efforts to include additional data and information, as specified
- AB 2976 (Quirk) would have required DPH to coordinate with the state entities, including DHCS, that are responsible for administering specified publicly funded programs to gather data to determine whether children are being screened for lead poisoning, as required pursuant to existing regulation. AB 2976 was held on the Senate Appropriations Committee suspense file.
- SB 775 (Ridley-Thomas) of 2007 would have, among other provisions, required DPH to make available on its Web site the most current information on lead, as specified, and would have required providers primarily responsible for providing prenatal care to explain to pregnant women that lead poisoning prevention information is available on the Web site or provide other information about lead poisoning prevention. SB 775 was vetoed by the Governor who indicated: “While I support programs to reduce lead exposure for children, this bill is duplicative of existing state requirements and may jeopardize overall funding for lead poisoning prevention. Many of the bill's provisions are unnecessary and are already being accomplished administratively.”
- AB 247 (Garcia) of 2017 would have established a Statewide Lead Advisory Taskforce to review and provide recommendations regarding policies and procedures to reduce lead poisoning in the state. AB 247 was vetoed by the Governor who indicated: “The responsibilities of this task force would be duplicative of ongoing work by the Office of Environmental Health Hazard Assessment, DPH, the State Water Resources Control Board, and the Department of Toxic Substances Control. Coordination and evaluation of procedures to reduce childhood lead poisoning is being accomplished administratively amongst these agencies so there is no reason to divert resources to a task force.”
- AB 2122 (Reyes) of 2018 would have: a) established requirements DHCS and MCMC care plans to ensure children receive blood lead screening, information about lead exposure and testing, and follow-up services for children with an elevated blood lead level, including a contractual requirement for plans and their contractors to meet the standard of care for lead testing; b) establishes state goals for children at risk of lead exposure and for blood testing for children under age who are eligible for Medi-Cal; c) requires DHCS to include blood lead screening tests as a plan performance measure in its annual External Accountability Set, and requires DHCS to annually create a report detailing the DHCS’ progress toward the state goals; and, d) require DPH to prepare provider training guidelines, curriculum, and resources that are required to be used to educate providers about childhood lead poisoning prevention, childhood lead exposure risks, childhood lead exposure health effects, and sources of childhood lead exposure at the state, regional, and local levels.
REGISTERED SUPPORT / OPPOSITION:
Support
California Pan-Ethnic Health Network
Coalition of California Welfare Rights Organizations, Inc.
Children Now
Environmental Working Group
National Association of Social Workers, California Chapter
Western Center on Law & Poverty, Inc.
Opposition
None on file.
Analysis Prepared by: Scott Bain / HEALTH / (916) 319-2097
Bill Author
Bill Co-Author(s):